Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Wednesday Ends With Index Decline | Wall Street Today
FDA Investigating Safety Risks of Bluebird's Skysona
FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Jaguar8 : That is the really the accompanying risk of being ina clinical trial. This kind of adverse events is just troubling. I wonder how high their attrition rate is
Trytosaveabit OP Jaguar8 : Yeah I know! It just sux! You have a drug that really helps just to find out later it can add to the already bad situation! Grrr
Jaguar8 Trytosaveabit OP : True. Some subjects even die
Trytosaveabit OP Jaguar8 : Yup! My Mom was in a trial!
Jaguar8 Trytosaveabit OP : and what happened?
View more comments...